Recent Security Class Actions

Nektar Therapeutics Common Stock (NASDAQ: NKTR)

21 Days left to seek lead plaintiff status.

Company Name:Nektar Therapeutics Common Stock
Stock Symbol:NASDAQ: NKTR
Class Period Start:02/26/2025
Class Period End (inclusive):12/15/2025
Filing Deadline:05/05/2026

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) enrollment in the REZOLVE-AA trial had not followed applicable instructions and protocol standards; (ii) the foregoing was likely to have a significant negative impact on the REZOLVE-AA trial’s results; (iii) accordingly, the REZOLVE-AA trial’s overall integrity and prospects were overstated; and (iv) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

Nektar Therapeutics Common Stock (NASDAQ: NKTR) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address